Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Finnish (OMX) Healthcare Sector Analysis

UpdatedJun 25, 2026
DataAggregated Company Financials
Companies13
  • 7D1.9%
  • 3M-1.6%
  • 1Y-2.5%
  • YTD-6.5%

In the last week, the Healthcare industry is up 2.2%, with Orion Oyj up 2.0%. In the past year, the industry is down 3.5%. Earnings are forecast to grow by 12% annually.

Sector Valuation and Performance

Has the Finnish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Jun 2026€11.9b€5.9b€576.3m16x20.7x2x
Sat, 23 May 2026€12.2b€5.9b€576.3m16.2x21.2x2.1x
Mon, 20 Apr 2026€12.9b€5.9b€561.2m17.3x23.1x2.2x
Wed, 18 Mar 2026€12.4b€5.9b€561.2m16.8x22.2x2.1x
Fri, 13 Feb 2026€12.2b€5.6b€366.1m16.2x33.4x2.2x
Sun, 11 Jan 2026€12.3b€5.6b€367.7m23.9x33.5x2.2x
Tue, 09 Dec 2025€11.5b€5.6b€367.7m23.9x31.2x2x
Thu, 06 Nov 2025€11.2b€5.6b€366.9m20x30.4x2x
Sat, 04 Oct 2025€12.3b€5.7b€419.6m19.4x29.4x2.2x
Mon, 01 Sep 2025€12.8b€5.7b€420.9m18.7x30.4x2.3x
Wed, 30 Jul 2025€13.2b€5.7b€427.5m18.3x30.8x2.3x
Fri, 27 Jun 2025€12.1b€5.5b€392.7m17.2x30.9x2.2x
Sun, 25 May 2025€11.6b€5.5b€392.7m18.6x29.6x2.1x
Tue, 22 Apr 2025€10.1b€5.4b€362.7m20.6x27.8x1.9x
Thu, 20 Mar 2025€11.3b€5.4b€364.7m20.9x31.1x2.1x
Sat, 15 Feb 2025€10.5b€5.2b€289.6m19.6x36.2x2x
Mon, 13 Jan 2025€9.5b€5.2b€274.3m25x34.7x1.8x
Wed, 11 Dec 2024€9.3b€5.2b€274.3m20.1x33.9x1.8x
Fri, 08 Nov 2024€9.3b€5.2b€274.2m23x34x1.8x
Sun, 06 Oct 2024€10.0b€5.0b€144.2m24.9x69.1x2x
Tue, 03 Sep 2024€10.1b€5.0b€143.6m25.2x70.5x2x
Thu, 01 Aug 2024€9.2b€5.0b€123.3m29.7x74.3x1.8x
Sat, 29 Jun 2024€8.5b€4.9b€115.7m28.3x73.7x1.7x
Mon, 27 May 2024€8.2b€4.9b€118.1m27.9x69.5x1.7x
Wed, 24 Apr 2024€7.4b€4.8b€108.0m30.1x68.7x1.5x
Fri, 22 Mar 2024€7.4b€4.8b€108.1m29x68.4x1.5x
Sun, 18 Feb 2024€8.3b€4.8b€110.2m27.6x75.3x1.7x
Tue, 16 Jan 2024€8.6b€4.8b€135.4m33.9x63.2x1.8x
Thu, 14 Dec 2023€7.6b€4.8b€135.4m29.8x55.9x1.6x
Sat, 11 Nov 2023€7.5b€4.8b€134.3m29.7x55.5x1.6x
Mon, 09 Oct 2023€7.8b€5.0b€270.4m27.2x29x1.6x
Wed, 06 Sep 2023€7.8b€5.0b€269.6m26.5x28.8x1.6x
Fri, 04 Aug 2023€7.3b€5.0b€277.7m24.7x26.5x1.5x
Sun, 02 Jul 2023€8.3b€5.0b€315.2m39.7x26.2x1.7x
Price to Earnings Ratio

26.2x


Total Market Cap: €8.3bTotal Earnings: €315.2mTotal Revenue: €5.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Finnish Healthcare Sector Price to Earnings3Y Average 41.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.5x which is lower than its 3-year average PE of 41.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 22% per year over the last three years.
  • Revenues for these companies have grown 5.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Finnish Healthcare sector?

FI Market-1.61%
Healthcare1.86%
Healthcare Services2.15%
Pharma1.98%
Medical Equipment0.63%
Biotech0%0
Life Sciences-3.83%
Healthtech-4.21%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 204x.
    • Analysts are expecting annual earnings growth of 31.1%, which is higher than its past year's earnings decline of 5.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 50% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 9.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ORNBV Orion Oyj€70.254.3%
+€408.5m		12.3%PE18.7x
TTALO Terveystalo Oyj€7.610.9%
+€8.9m		-31.2%PE12.6x
REG1V Revenio Group Oyj€12.721.6%
+€5.3m		-53.8%PE21.5x
OPTOMED Optomed Oyj€1.8611.3%
+€4.0m		-55.8%PS2.4x
HEALTH Nightingale Health Oyj€0.857.0%
+€3.4m		-67.4%PS10.8x

Latest News

TTALO
€7.61
Terveystalo Oyj
7D
0.9%
1Y
-31.2%
Narrative Update • Jun 24

TTALO: Lower Profitability Outlook Will Still Support Long-Term Upside Potential

Analysts have trimmed their price target for Terveystalo Oyj from €9.95 to €9.20, citing updated assumptions on the discount rate, revenue growth, profit margin and future P/E that collectively point to a lower fair value estimate. What's in the News Terveystalo Oyj has scheduled a Special and Extraordinary Shareholders Meeting for Jun 30, 2026, at 14:30 FLE Standard Time (source: Key Developments).
ORNBV
€70.25
Orion Oyj
7D
4.3%
1Y
12.3%
BRETEC
€0.023
Bioretec Oy
7D
7.5%
1Y
-98.7%
REG1V
€12.72
Revenio Group Oyj
7D
1.6%
1Y
-53.8%
Narrative Update • Jun 16

REG1V: Street Downgrades Will Set Up Future Upside Repricing

Analysts maintained their fair value estimate for Revenio Group Oyj at €18.0. A slightly lower discount rate and a marginally reduced future P/E assumption reflect more cautious sentiment following recent downgrades in Street research. Analyst Commentary on Revenio Group Oyj Recent Street research on Revenio Group Oyj has turned more cautious, with multiple downgrades pointing to concerns that contrast with the fair value estimate being held at €18.0. For you as an investor, the key is to distinguish where analysts still see support for the valuation from where they see growing execution and growth risks.
HEALTH
€0.85
Nightingale Health Oyj
7D
7.0%
1Y
-67.4%
Narrative Update • Jun 16

HEALTH: Future Upside Will Rely On Shifting Project Revenue Execution

Analysts have reduced their fair value estimate for Nightingale Health Oyj stock from €1.70 to €1.40, citing slightly more conservative assumptions for revenue growth, profit margins, and the future P/E multiple. What’s in the News for Nightingale Health Oyj Nightingale Health Oyj lowered its earnings guidance for the financial year 2025–2026 after revising its revenue growth expectations, citing more conservative assumptions for the period.
MODU
€1.14
Modulight Oyj
7D
-3.4%
1Y
-2.3%
Narrative Update • Jun 10

MODU: Confirmed Guidance And Committee Refresh Will Support Very High Future P/E

Analysts have reiterated their €1.60 price target for Modulight Oyj, with only minor tweaks to inputs such as the discount rate and long run P/E assumption. This reflects updated views on risk and valuation while keeping the overall target unchanged.
BIOBV
€2.43
Biohit Oyj
7D
-0.4%
1Y
-10.0%
NANOFH
€0.84
Nanoform Finland Oyj
7D
-1.9%
1Y
-12.6%
NXTMH
€9.89
Nexstim
7D
-0.5%
1Y
-16.5%
OPTOMED
€1.86
Optomed Oyj
7D
11.3%
1Y
-55.8%
AIFORIA
€1.77
Aiforia Technologies Oyj
7D
-4.7%
1Y
-46.5%
PIHLIS
€10.24
Pihlajalinna Oyj
7D
-1.9%
1Y
-34.1%
ORIOLA
€0.90
Oriola Oyj
7D
1.1%
1Y
-14.4%